In myeloma treatment, acute CRS is a common but treatable AE associated with CAR T-cell therapy and bispecific antibodies, ...

Restaging cancer can be an unfamiliar space, but with more experience, APPs can rely less on MDs for guidance in such cases.

Experts discuss the patient case of Janet, a 58-year-old with her 2 positive metastatic breast cancer, and after 14 months on ...

Patients with recurrent/metastatic HER2-positive breast cancer experienced durable response and manageable safety from ...

While ambient particle levels differed by HEPA filter status, Splashblocker significantly reduced particles emitted from toilet plume aerosols regardless.

Working with multidisciplinary teams and educating patients are key to treating patients with cancer while navigating newly approved treatments.

Patients receiving ponsegromab experienced significantly greater weight gain and physical activity than those receiving placebo.

Real-World Data Back First-Line Avelumab and Axitinib in Advanced RCC ...

Real-World Data Back First-Line Avelumab and Axitinib in Advanced RCC ...

Real-World Data Back First-Line Avelumab and Axitinib in Advanced RCC ...

Real-World Data Back First-Line Avelumab and Axitinib in Advanced RCC ...

Real-World Data Back First-Line Avelumab and Axitinib in Advanced RCC ...